- Home
- FOXX vs ANTX Comparison
FOXX vs ANTX Comparison
Compare FOXX & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXX
- ANTX
- Stock Information
- Founded
- FOXX 2017
- ANTX 2017
- Country
- FOXX United States
- ANTX United States
- Employees
- FOXX N/A
- ANTX N/A
- Industry
- FOXX
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- FOXX
- ANTX Health Care
- Exchange
- FOXX Nasdaq
- ANTX Nasdaq
- Market Cap
- FOXX 30.5M
- ANTX 34.4M
- IPO Year
- FOXX N/A
- ANTX 2022
- Fundamental
- Price
- FOXX $4.00
- ANTX $1.23
- Analyst Decision
- FOXX
- ANTX Buy
- Analyst Count
- FOXX 0
- ANTX 2
- Target Price
- FOXX N/A
- ANTX $2.00
- AVG Volume (30 Days)
- FOXX 24.5K
- ANTX 64.6K
- Earning Date
- FOXX 11-18-2025
- ANTX 11-12-2025
- Dividend Yield
- FOXX N/A
- ANTX N/A
- EPS Growth
- FOXX N/A
- ANTX N/A
- EPS
- FOXX N/A
- ANTX N/A
- Revenue
- FOXX $65,919,166.00
- ANTX N/A
- Revenue This Year
- FOXX N/A
- ANTX N/A
- Revenue Next Year
- FOXX N/A
- ANTX N/A
- P/E Ratio
- FOXX N/A
- ANTX N/A
- Revenue Growth
- FOXX 1941.75
- ANTX N/A
- 52 Week Low
- FOXX $2.45
- ANTX $0.98
- 52 Week High
- FOXX $11.00
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- FOXX 37.13
- ANTX 48.89
- Support Level
- FOXX $4.09
- ANTX $1.14
- Resistance Level
- FOXX $4.78
- ANTX $1.36
- Average True Range (ATR)
- FOXX 0.26
- ANTX 0.07
- MACD
- FOXX 0.04
- ANTX 0.00
- Stochastic Oscillator
- FOXX 0.00
- ANTX 43.48
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.